Overview

Psilocybin Therapy for Depression in Bipolar II Disorder

Status:
Not yet recruiting
Trial end date:
2023-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety, tolerability, and feasibility of psilocybin therapy in people with Bipolar II Disorder.
Phase:
Phase 2
Details
Lead Sponsor:
University of California, San Francisco
Treatments:
N,N-Dimethyltryptamine
Psilocybin